Association Between Biologics Use and Risk of Serious Infection in Patients With Psoriasis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Association Between Biologics Use and Risk of Serious Infection in Patients With Psoriasis
Authors
Keywords
-
Journal
JAMA Dermatology
Volume 157, Issue 9, Pages 1056
Publisher
American Medical Association (AMA)
Online
2021-07-21
DOI
10.1001/jamadermatol.2021.2599
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Psoriasis
- (2021) Christopher E M Griffiths et al. LANCET
- Risk of Hospitalized Serious Infection After Initiating Ustekinumab or Other Biologics for Psoriasis or Psoriatic Arthritis
- (2021) Yinzhu Jin et al. ARTHRITIS CARE & RESEARCH
- Unknown
- (2019) BRITISH JOURNAL OF DERMATOLOGY
- Risk of Serious Infection in Patients Receiving Systemic Medications for the Treatment of Psoriasis
- (2019) Erica D. Dommasch et al. JAMA Dermatology
- Comparative risk of serious infections among real-world users of biologics for psoriasis or psoriatic arthritis
- (2019) Xintong Li et al. ANNALS OF THE RHEUMATIC DISEASES
- ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents targeting interleukins, immunoglobulins and complement factors)
- (2018) K.L. Winthrop et al. CLINICAL MICROBIOLOGY AND INFECTION
- Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases
- (2018) Julien Kirchgesner et al. GASTROENTEROLOGY
- Comparison of Drug Discontinuation, Effectiveness, and Safety Between Clinical Trial Eligible and Ineligible Patients in BADBIR
- (2018) Kayleigh J. Mason et al. JAMA Dermatology
- Adherence and resource use among psoriasis patients treated with biologics
- (2018) Joseph S. Aleshaki et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Effectiveness and Safety of Reference Infliximab and Biosimilar in Crohn Disease: A French Equivalence Study
- (2018) Antoine Meyer et al. ANNALS OF INTERNAL MEDICINE
- Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease
- (2017) Magali Lemaitre et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Infections in Moderate to Severe Psoriasis Patients Treated with Biological Drugs Compared to Classic Systemic Drugs: Findings from the BIOBADADERM Registry
- (2017) Paula Dávila-Seijo et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Serious infections among a large cohort of subjects with systemically treated psoriasis
- (2017) Allison S. Dobry et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Unknown
- (2017) JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Value of a national administrative database to guide public decisions: From the système national d’information interrégimes de l’Assurance Maladie (SNIIRAM) to the système national des données de santé (SNDS) in France
- (2017) P. Tuppin et al. REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE
- Risk of Multiple Sclerosis in Patients with Psoriasis: A Danish Nationwide Cohort Study
- (2016) Alexander Egeberg et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Risk of Serious Infections in Patients with Psoriasis on Biologic Therapies: A Systematic Review and Meta-Analysis
- (2016) Zenas Z.N. Yiu et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Unknown
- (2016) PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: cohort study
- (2016) Alain Weill et al. BMJ-British Medical Journal
- Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: cohort study
- (2016) Alain Weill et al. BMJ-British Medical Journal
- Unknown
- (2016) BRITISH JOURNAL OF DERMATOLOGY
- Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
- (2015) Richard B. Warren et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- European S3-Guidelines on the systemic treatment of psoriasis vulgaris - Update 2015 - Short version - EDF in cooperation with EADV and IPC
- (2015) A. Nast et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Risk of Serious Infection With Biologic and Systemic Treatment of Psoriasis
- (2015) Robert E. Kalb et al. JAMA Dermatology
- Risk of Serious Adverse Events Associated With Biologic and Nonbiologic Psoriasis Systemic Therapy
- (2012) Gregorio Carretero ARCHIVES OF DERMATOLOGY
- Hospitalization admission rates for low-income subjects with full health insurance coverage in France
- (2010) P. Tuppin et al. EUROPEAN JOURNAL OF PUBLIC HEALTH
- Use of Stabilized Inverse Propensity Scores as Weights to Directly Estimate Relative Risk and Its Confidence Intervals
- (2009) Stanley Xu et al. VALUE IN HEALTH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started